Company news

Boston Scientific Corporation (NYSE:BSX) news

Every Boston Scientific Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Boston Scientific Corporation stock analysis →

Press releases & updates

Boston Scientific announces results for second quarter 2026

July 29, 2026

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectivene...

May 19, 2026

Boston Scientific enters into $2 billion accelerated share repurchase agreement

May 18, 2026

Boston Scientific announces strategic investment in MiRus LLC

May 18, 2026

FDA issues most serious recall for certain pacemaker devices by Boston Scientific

May 8, 2026

Penumbra, Inc. Reports First Quarter 2026 Financial Results

May 6, 2026

Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second...

May 4, 2026

Liftoff Welcomes Former J.D. Power CEO, Dave Habiger and Former Apple Controller, Betsy Rafael to its Board of Directors

April 30, 2026

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

April 26, 2026

Boston Scientific announces results for first quarter 2026

April 22, 2026

Envoy Medical Appoints Chas McKhann to Board of Directors

April 16, 2026

CIRCA Scientific Appoints MedTech Executive Vafa Jamali to Board of Directors

April 9, 2026

Boston Scientific announces conference call discussing first quarter 2026 results

March 30, 2026

CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all p...

March 28, 2026

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary...

March 28, 2026

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

March 6, 2026

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

February 25, 2026

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

February 23, 2026

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

February 13, 2026

Boston Scientific announces results for fourth quarter and full year 2025

February 4, 2026

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

January 30, 2026

DATAMYTE RELEASES QPS PRO TO MEET AUTOMOTIVE OEM'S INCREASING DIGITAL QUALITY REQUIREMENTS

January 21, 2026

Boston Scientific announces agreement to acquire Penumbra, Inc.

January 15, 2026

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

January 12, 2026

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full...

January 2, 2026

CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5

December 10, 2025

Workday Recognized as a Leader in 2025 Gartner® Magic Quadrant™ for Financial Planning Software for Fourth Year in a Row

December 4, 2025

Novatize Named "B2B eCommerce Agency of the Year" at the Americas B2B eCommerce Industry Awards

November 12, 2025

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Fu...

November 6, 2025

Boston Scientific announces upcoming investor conference schedule

November 3, 2025

Boston Scientific announces results for third quarter 2025

October 22, 2025

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

October 17, 2025

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

October 1, 2025

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

September 9, 2025

Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

September 2, 2025

Cirtec Medical Announces Appointment of New Chief Executive Officer

August 28, 2025

REALIZE Demo Day to Spotlight Health Tech Startups with Expert Insights and Investor Feedback

August 27, 2025

Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption

August 14, 2025

Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results W...

August 6, 2025

CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in A...

August 5, 2025

Boston Scientific announces results for second quarter 2025

July 23, 2025

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

July 7, 2025

Boston Scientific announces conference call discussing second quarter 2025 results

July 1, 2025

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

April 24, 2025

Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed B...

April 23, 2025

Boston Scientific announces results for first quarter 2025

April 23, 2025

Boston Scientific announces conference call discussing first quarter 2025 results

April 1, 2025

Boston Scientific announces agreement to acquire SoniVie Ltd.

March 3, 2025

Boston Scientific announces completion of €1.5 billion offering of senior notes

February 26, 2025

Boston Scientific announces pricing of €1.5 billion of senior notes

February 21, 2025

Older →